Who is sponsoring NCT03832777?

NCT03832777 is sponsored by Universidad Autonoma de Queretaro.

What drugs are being tested in NCT03832777?

Interventions in NCT03832777: Repetitive Transcranial Magnetic Stimulation.

What condition does NCT03832777 study?

NCT03832777 studies Borderline Personality Disorder.

Is NCT03832777 still recruiting?

NCT03832777 is currently status unknown. Last updated 15 February 2019.

Last reviewed 2019-02-15 · How we verify

NCT03832777: TMS&BPD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transcranial Magnetic Stimulation on Dorsomedial Prefrontal Cortex in Borderline Personality Disorder

Status unknown NA Last updated 15 February 2019

What this trial tests

NA trial testing Repetitive Transcranial Magnetic Stimulation in Borderline Personality Disorder in 20 participants. Status unknown.

Timeline

5 March 2018

Primary endpoint
30 January 2019

30 August 2019

Quick facts

Lead sponsor	Universidad Autonoma de Queretaro
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	5 March 2018
Primary completion	30 January 2019
Estimated completion	30 August 2019
Sites	1 location across Mexico

Drugs / interventions tested

Repetitive Transcranial Magnetic Stimulation

Conditions studied

Borderline Personality Disorder — all drugs for Borderline Personality Disorder →

Sponsor

Universidad Autonoma de Queretaro

Who can join

Adults 18 to 45, any sex, with Borderline Personality Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the effect of 5Hz repetitive Transcranial Magnetic Stimulation (rTMS) on Dorsomedial Prefrontal Cortex on Borderline Personality Disorder (BPD).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Improvement in borderline personality disorder symptomatology after repetitive transcranial magnetic stimulation of the dorsomedial prefrontal cortex: preliminary results.
Calderón-Moctezuma AR, Reyes-López JV, Rodríguez-Valdés R, Barbosa-Luna M, et al · · 2020 · cited 18× · PMID 32876128 · DOI 10.1590/1516-4446-2019-0591

Verify or expand the search:

Other trials of Repetitive Transcranial Magnetic Stimulation

Trials testing the same drug.

NCT07278206 — Brain Stimulation in Long COVID · NA · recruiting
NCT07211490 — rTMS for Cerebellar Ataxia in Children · NA · not yet recruiting
NCT05139862 — Neurocardiac Predictors of Treatment Response to RTMS in Depression · NA · not yet recruiting
NCT05883774 — Effects of rTMS on the Anxiety State of Older Patients With GAD · NA · not yet recruiting
NCT06490965 — Improving Obsessive-compulsive Disorder Treatments: from Lesions to Neuromodulation Targets · NA · recruiting

Other recruiting trials for Borderline Personality Disorder

Currently open trials in the same condition.

NCT06458933 — Testing Interventions for Borderline Personality Disorder. · Phase 2 · recruiting
NCT07001475 — A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperact · Phase 1 · recruiting
NCT07119541 — Testing an Alliance-Focused Dialectical Behaviour Therapy Training for Borderline Personality Disorder · NA · active not recruiting
NCT06446765 — Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder · Phase 2 · recruiting
NCT07197502 — Treatment of Borderline Personality Disorder With rTMS · NA · recruiting

Other Universidad Autonoma de Queretaro trials

Trials by the same sponsor.

NCT06817070 — Diet, Exercise, and Nutrition Challenges in Mexican Adults During COVID-19: A Study · completed
NCT03906903 — Transcranial Magnetic Stimulation and Cognitive Stimulation in Mild Cognitive Impairment · NA · unknown
NCT03540641 — Transcranial Magnetic Stimulation (TMS) in Binge Eating Disorder (BED) · NA · completed
NCT05288101 — Effect of Oral Nutritional Supplementation Combined With Impedance Vectors · NA · completed
NCT03571412 — Antidepressive Effect on 5 Herz (Hz) rTMS Over Dorsomedial Prefrontal Cortex and Left Dorsolateral Prefrontal Cortex · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03832777 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Autonoma de Queretaro
Last refreshed: 15 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03832777.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing